Based on the current evidence on the extremely rare occurrence of blood clots, the benefits of the Astra Zeneca vaccine continue to outweigh the risks for the large majority of people.
As a precaution, the Medicines and Healthcare products Regulatory Agency and the Joint Committee for Vaccination and Immunisations have suggested that those age 18-29 be offered an alternative vaccine, when eligible.
People who are age 18-29 and have already received their first dose of AstraZeneca should still attend for their second dose appointment.
People age 30 and over remain unaffected by the change in policy for under 30s.
People of any age with a higher risk of blood clots should discuss the benefits and risks with their GP to identify the right vaccine for them.
Everyone should continue to get their vaccination when asked to do so unless specifically advised otherwise. The benefits of vaccination continue to outweigh the risks.
[Source: Bexley Together]